Dr. Michael Robert Scoma, MD

Dr. Scoma practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Dr. Scoma's NPI, 1215167390, was assigned on July 22, 2009. Dr. Scoma holds New York license 257035.

Dr. Scoma's primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Dr. Scoma's primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Dr. Scoma is also affiliated with Tisch Hospital. Dmand AI also links Dr. Scoma to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scoma practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Scoma's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Scoma is licensed in New York.

CMS data shows 9,817 Medicare services from Dr. Scoma across 2 procedure codes in 2024, for 1,000 Medicare patients. Medicare paid $737,704 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,000 Medicare patients who saw Dr. Scoma in 2024. The largest group is 75 to 84, with 372 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scoma's median patient age at 57, with 56% women.

In 2024, Dr. Scoma wrote 840 Medicare Part D claims for 141 patients. 90% of them were for generic drugs. CMS names the drug for 718 of them, across 16 drugs with 11 or more claims each, at $292,740 in total drug cost. In 2023, CMS named 765 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Scoma for performance year 2024, reported individually. Dr. Scoma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Scoma from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $382.